Sunday, February 07, 2021 6:14:14 AM
To bad here, but understand that the Bond Holders have $450 million claim on company assets, and even in a Chapter 11 reorganization the common stock gets cancelled, just the way it works.
The chapter 15 is liquidation, which means there is no attempt to reorganize and the common stock automatically is cancelled as worthless.
IMO you have a blessing to still be able to sell this, as most people don't understand what they are dealing with.
Good luck
Recent LKNCY News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 11:24:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:34:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 12:00:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 04:40:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/16/2023 11:30:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 11:35:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/10/2023 02:28:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2023 09:09:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 11:00:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/07/2023 02:31:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2023 11:35:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:09:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:03:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM